3KYG image
Deposition Date 2009-12-06
Release Date 2010-04-14
Last Version Date 2024-05-29
Entry Detail
PDB ID:
3KYG
Title:
Crystal structure of VCA0042 (L135R) complexed with c-di-GMP
Biological Source:
Source Organism:
Vibrio cholerae (Taxon ID: 666)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.10 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Putative uncharacterized protein VCA0042
Gene (Uniprot):VC_A0042
Mutagens:L135R
Chain IDs:A, B
Chain Length:227
Number of Molecules:2
Biological Source:Vibrio cholerae
Ligand Molecules
Primary Citation
Structure of PP4397 Reveals the Molecular Basis for Different c-di-GMP Binding Modes by Pilz Domain Proteins.
J.Mol.Biol. 398 97 110 (2010)
PMID: 20226196 DOI: 10.1016/j.jmb.2010.03.007

Abstact

Cyclic diguanylate (c-di-GMP) is a global regulator that modulates pathogen virulence and biofilm formation in bacteria. Although a bioinformatic study revealed that PilZ domain proteins are the long-sought c-di-GMP binding proteins, the mechanism by which c-di-GMP regulates them is uncertain. Pseudomonas putida PP4397 is one such protein that contains YcgR-N and PilZ domains and the apo-PP4397 structure was solved earlier by the Joint Center for Structural Genomics. We determined the crystal structure of holo-PP4397 and found that two intercalated c-di-GMPs fit into the junction of its YcgR-N and PilZ domains. Moreover, c-di-GMP binding induces PP4397 to undergo a dimer-to-monomer transition. Interestingly, another PilZ domain protein, VCA0042, binds to a single molecule of c-di-GMP, and both its apo and holo forms are dimeric. Mutational studies and the additional crystal structure of holo-VCA0042 (L135R) showed that the Arg122 residue of PP4397 is crucial for the recognition of two molecules of c-di-GMP. Thus, PilZ domain proteins exhibit different c-di-GMP binding stoichiometry and quaternary structure, and these differences are expected to play a role in generating diverse forms of c-di-GMP-mediated regulation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures